I always felt a strong connection to the Duchenne community while working at the NIH. As you know, that connection and the incredible work of organizations like PPMD inspired me to jump full-time into the fight to end Duchenne. Yesterday’s FDA and NIH dystrophin methodology workshop really cemented that decision for me. Never have I been more proud to be part of a rare disease community and par…